可能与多 (ADP-Ribose) 聚合酶抑制剂相关的外围神经病变:对Eudravigilance数据库的分析
Mafalda Jesus1,2, António Cabral1,3, Cristina Monteiro1,2,4
1Health Sciences Faculty, University of Beira Interior (FCS-UBI), 6200-506 Covilhã, Portugal.
Current oncology (Toronto, Ont.)
|July 28, 2023
概括
多 (ADP-Ribose) 聚合酶抑制剂 (PARPi) 在癌症治疗中表现有前途. 然而,对EudraVigilance数据的分析显示,外围神经病变是一种显著的不良药物反应,特别是与niraparib.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 多 (ADP-Ribose) 聚合酶抑制剂 (PARPi) 是一种向癌症治疗类.
- 在各种癌症类型中,PARPi已经证明了其有效性.
- 了解它们的药物不良反应 (ADR) 概况对于患者的安全至关重要.
研究的目的:
- 使用EudraVigilance (EV) 数据库调查与PARPi相关的不良反应.
- 具体分析PARPi与外围神经病变之间的关联.
- 为了确定不同PARPi药物之间不良反应的潜在差异.
主要方法:
- 从EudraVigilance数据库中检索了12762个个案安全报告 (ICSR).
- 专注分析严重的神经系统障碍.
- 对报告的副作用的评估结果和管理策略.
主要成果:
- 周围神经病变被确定为与PARPi相关的显著ADR.
- 与其他PARPi相比,Niraparib显示了较高的外围神经病变报告频率.
- 许多外围神经病变病例导致未解决的症状,需要戒药.
结论:
- 虽然PARPi提供治疗效益,但外围神经病是需要注意的显著ADR.
- 尼拉帕里布由于与外围神经病变的关联,因此需要特别关注药监.
- 需要进一步的研究,以充分阐明PARPi诱导的副作用的毒性概况和管理.
相关概念视频
Pharmacovigilance
891
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
891
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Peripheral Artery Disease I: Introduction
10
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
10
Peripheral Artery Disease IV: Nursing Management
12
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
12
Local Anesthetics: Differential Sensitivity of Nerve Fibers
870
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
870
Peripheral Artery Disease V: Postoperative Nursing Management
12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12


